Furthermore, the expression patterns of the transgenes in these mouse lines promoted different types of tumors, yielding almost exclusively B-cell lymphomas in the Eμ-c-myc transgenic mice, whereas the H2K-myc transgenic mice developed mainly T-cell lymphomas. This evidence concerns the gene MYC and T-cell non-Hodgkin lymphoma.